JP2020503280A5 - - Google Patents

Download PDF

Info

Publication number
JP2020503280A5
JP2020503280A5 JP2019530099A JP2019530099A JP2020503280A5 JP 2020503280 A5 JP2020503280 A5 JP 2020503280A5 JP 2019530099 A JP2019530099 A JP 2019530099A JP 2019530099 A JP2019530099 A JP 2019530099A JP 2020503280 A5 JP2020503280 A5 JP 2020503280A5
Authority
JP
Japan
Prior art keywords
alkyl
cancer
aryl
chain
mitochondrial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019530099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020503280A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/058508 external-priority patent/WO2018122789A1/en
Publication of JP2020503280A publication Critical patent/JP2020503280A/ja
Publication of JP2020503280A5 publication Critical patent/JP2020503280A5/ja
Priority to JP2022200267A priority Critical patent/JP7689690B2/ja
Pending legal-status Critical Current

Links

JP2019530099A 2016-12-29 2017-12-29 ヒドロキシ安息香酸誘導体、その方法および使用 Pending JP2020503280A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022200267A JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT10981816 2016-12-29
PT109818 2017-12-29
PCT/IB2017/058508 WO2018122789A1 (en) 2016-12-29 2017-12-29 Hydroxybenzoic acid derivatives, methods and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022200267A Division JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Publications (2)

Publication Number Publication Date
JP2020503280A JP2020503280A (ja) 2020-01-30
JP2020503280A5 true JP2020503280A5 (https=) 2021-03-04

Family

ID=61074472

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019530099A Pending JP2020503280A (ja) 2016-12-29 2017-12-29 ヒドロキシ安息香酸誘導体、その方法および使用
JP2022200267A Active JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022200267A Active JP7689690B2 (ja) 2016-12-29 2022-12-15 ヒドロキシ安息香酸誘導体、その方法および使用

Country Status (8)

Country Link
US (1) US11078222B2 (https=)
EP (1) EP3562830B1 (https=)
JP (2) JP2020503280A (https=)
KR (1) KR102750630B1 (https=)
CN (1) CN110114365B (https=)
BR (1) BR112019011303B1 (https=)
CA (1) CA3048966A1 (https=)
WO (1) WO2018122789A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021085906A1 (ko) * 2019-10-30 2021-05-06 주식회사 퓨전바이오텍 미토콘드리아 표적 화합물 및 이를 포함하는 노화 관련 질환의 치료 또는 예방을 위한 조성물
WO2023053059A1 (en) * 2021-09-30 2023-04-06 Universidade Do Porto Antifouling compound, method and uses thereof
US20250312360A1 (en) * 2022-05-13 2025-10-09 Virginia Tech Intellectual Properties, Inc. Mitochondrial antioxidant treatment for cask-linked neurodevelopmental disorders
KR20240040435A (ko) * 2022-09-21 2024-03-28 울산과학기술원 미토콘드리아 표적 화합물을 유효성분으로 포함하는 망막 변성 치료용 약학적 조성물
KR102894216B1 (ko) * 2022-12-15 2025-12-18 울산과학기술원 Trap-1 억제제
CN116210697B (zh) * 2023-03-02 2024-05-14 西北农林科技大学 反式肉桂酸在提高苹果树腐烂病抗性中的应用
KR20250126454A (ko) * 2024-02-16 2025-08-25 울산과학기술원 암 세포의 티오에스테라제 및 활성산소종에 의해 자가 조립 중합되는 단량체 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102459291B (zh) * 2009-04-27 2015-11-25 Mcw研究基金会股份有限公司 神经保护性化合物和它们的应用
GB201320636D0 (en) * 2013-11-22 2014-01-08 Medical Res Council Compounds
WO2017155991A1 (en) * 2016-03-08 2017-09-14 The Regents Of The University Of Michigan Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity
CN109843896B (zh) * 2016-10-14 2022-12-20 波尔图大学 羟基肉桂酸衍生物、方法及其用途

Similar Documents

Publication Publication Date Title
JP2020503280A5 (https=)
JOP20220069A1 (ar) عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها
US20240262840A1 (en) Heterocyclic flavone derivatives, compositions, and methods related thereto
JP2023051961A5 (https=)
EP3630101B1 (en) Tegavivint for use in the treatment of pulmonary fibrosis
TN2013000293A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
JP7341034B2 (ja) プロテオパチーの処置のためのベンジリデングアニジン誘導体の新規な治療的使用
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
MX2018001196A (es) Compuesto derivado de amida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6 y composición farmacéutica que lo contiene.
NZ740429A (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
CA2851996A1 (en) Pharmaceutical compositions for substituted quinazolinones
KR20180058829A (ko) Ezh2 억제제로 수모세포종을 치료하는 방법
SG11201806438UA (en) Fused Pyrazole Derivatives, Preparation Method Thereof, And Use Thereof In Treatment Of Cancers, Inflammation And Immune Diseases
JP6243849B2 (ja) 口腔用組成物及び口腔用活性酸素消去剤
NO20092117L (no) Nye lipidforbindelser
AU2015204609B2 (en) Novel functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy
EP4226919A1 (en) Ferroptosis inhibitor
BR112019010816A2 (pt) composto de fórmula i, composto de fórmula ii, composto de fórmula iii, composto de fórmula iv, composto de fórmula v, composição farmacêutica, compostos, composto de fórmula viii, composto de fórmula ix, e composto de fórmula x
JP2023503613A (ja) 癌の処置のためにタキサンと共にfabp5阻害剤を使用する併用療法
CN112654355A (zh) 用于骨骼肌调节的raf-1激酶抑制剂化合物、其方法和用途
JP2021105061A (ja) アミロイド線維形成の抑制又は阻害剤
CN112930337B (zh) 抗增殖活性的苯氧基(杂)芳基醚
US20220315544A1 (en) Uses of doxadiazines compounds
WO2017219086A1 (en) Anti-ageing compounds
CA3127654A1 (en) Cannabidiol and/or derivatives thereof for use in the treatment of mitochondrial diseases